KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Accounts Payables (2016 - 2025)

Johnson & Johnson (JNJ) has disclosed Accounts Payables for 17 consecutive years, with $12.0 billion as the latest value for Q4 2025.

  • Quarterly Accounts Payables rose 16.29% to $12.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.0 billion through Dec 2025, up 16.29% year-over-year, with the annual reading at $12.0 billion for FY2025, 16.29% up from the prior year.
  • Accounts Payables hit $12.0 billion in Q4 2025 for Johnson & Johnson, up from $9.6 billion in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $12.0 billion in Q4 2025 to a low of $8.2 billion in Q1 2024.
  • Historically, Accounts Payables has averaged $9.6 billion across 5 years, with a median of $9.5 billion in 2025.
  • Biggest five-year swings in Accounts Payables: rose 28.66% in 2021 and later decreased 17.71% in 2023.
  • Year by year, Accounts Payables stood at $9.0 billion in 2021, then grew by 13.3% to $10.2 billion in 2022, then fell by 5.13% to $9.6 billion in 2023, then grew by 7.05% to $10.3 billion in 2024, then rose by 16.29% to $12.0 billion in 2025.
  • Business Quant data shows Accounts Payables for JNJ at $12.0 billion in Q4 2025, $9.6 billion in Q3 2025, and $9.5 billion in Q2 2025.